企業プロフィール
Sage Therapeutics, Inc. 株価・ニュース・カタリスト
- ティッカー:
- SAGE
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for SAGE.
企業概要
事業概要
Sage Therapeutics is a neuroscience company focused on neuropsychiatry, depression, and other CNS disorders.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Sage sits in specialty neuroscience biotech.
ビジネスモデルの特徴
The company combines commercial execution around CNS medicines with ongoing development in brain-health programs.
バイオ業界での位置付け
Sage is a CNS catalyst name whose stock tends to move sharply on clinical, commercial, and partnership developments.
今後のカタリスト
- Sage Therapeutics's catalysts are ZURZUVAE commercialization economics and any next-step CNS update that clarifies whether the company still has a growth path after the reset. The stock remains highly sensitive to whether the launch base can stabilize.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。